Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class Ii-Restricted Peptides from Melanoma-Associated Antigens

Cancer vaccines targeting CD8(+) T cells have been successful in eliciting immunologic responses but disappointing in inducing clinical responses. Strong evidence supports the importance of CD4(+) T cells in “helping” cytotoxic CD8(+) cells in antitumor immunity. We report here on two consecutive cl...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Phan, Giao Q., Touloukian, Christopher E., Yang, James C., Restifo, Nicholas P., Sherry, Richard M., Hwu, Patrick, Topalian, Suzanne L., Schwartzentruber, Douglas J., Seipp, Claudia A., Freezer, Linda J., Morton, Kathleen E., Mavroukakis, Sharon A., White, Donald E., Rosenberg, Steven A.
Format: Artigo
Langue:Inglês
Publié: 2003
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1679660/
https://ncbi.nlm.nih.gov/pubmed/12843797
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires